Literature DB >> 3141948

The economic impact of alcohol abuse and alcoholism.

T R Burke1.   

Abstract

The economic effects of alcohol abuse are as damaging to the nation as the health effects, affecting the family, the community, and persons of all ages. Underaged drinking is interfering with children's development, affecting the nation's ability to respond to economic challenge in the future. The college aged may be the most difficult to educate about alcohol abuse because of drinking patterns established at an early age and susceptibility to advertising inducements. Health care costs for families with an alcoholic member are twice those for families without one, and up to half of all emergency room admissions are alcohol related. Fetal alcohol syndrome is one of the top three known causes of birth defects, and is totally preventable. Alcohol abuse and alcoholism are estimated to have cost the nation $117 billion in 1983, while nonalcoholic drug abuse that year cost $60 billion. Costs of alcohol abuse are expected to be $136 billion a year by 1990, mostly from lost productivity and employment. Between 6 and 7 million workers are alcoholic, with an undetermined loss of productivity, profits, and competitiveness of American business. Alcohol abuse contributes to the high health care costs of the elderly beneficiaries of Federal health financing programs. Heavily affected minorities include blacks, Hispanics, and Native Americans. Society tends to treat the medical and social consequences of alcohol abuse, rather than its causes. Although our experience with the consequences of alcohol abuse is greater than that for any other drug, public concern for its prevention and treatment is less than for other major illnesses or abuse of other drugs. Alcohol abuse is a problem being given high priority within the Department in an effort to create a national agenda on the issue and to try to impart a greater sense of urgency about the problems. Ways are being explored to integrate alcoholism activities into more Departmental programs. Employee assistance programs for alcohol abuse have been established in about 90 percent of major companies, and Federal employees' access to treatment is being expanded through health insurance coverage. Collective public efforts are required to encourage prevention and treatment efforts, and to begin to reduce the economic effects of alcohol abuse that the country can no longer afford.

Entities:  

Mesh:

Year:  1988        PMID: 3141948      PMCID: PMC1478160     

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  6 in total

1.  Occupation as an independent risk factor for binge drinking.

Authors:  Andrew James Barnes; E Richard Brown
Journal:  Am J Drug Alcohol Abuse       Date:  2012-07-02       Impact factor: 3.829

2.  Drug use, drug prohibition and minority communities.

Authors:  P R Clifford
Journal:  J Prim Prev       Date:  1992-06

3.  Acamprosate. Pharmacoeconomic implications of therapy.

Authors:  R H Foster; K J McClellan
Journal:  Pharmacoeconomics       Date:  1999-12       Impact factor: 4.981

4.  Exploring productivity outcomes from a brief intervention for at-risk drinking in an employee assistance program.

Authors:  Karen Chan Osilla; Erin dela Cruz; Jeremy N V Miles; Steven Zellmer; Katherine Watkins; Mary E Larimer; G Alan Marlatt
Journal:  Addict Behav       Date:  2009-10-20       Impact factor: 3.913

5.  Nutritional Status and Diet Style Affect Cognitive Function in Alcoholic Liver Disease.

Authors:  Ye Rin Choi; Hyeong Seop Kim; Sang Jun Yoon; Na Young Lee; Haripriya Gupta; Ganesan Raja; Yoseph Asmelash Gebru; Gi Soo Youn; Dong Joon Kim; Young Lim Ham; Ki Tae Suk
Journal:  Nutrients       Date:  2021-01-09       Impact factor: 5.717

6.  Socioeconomic resources and quality of life in alcohol use disorder patients: the mediating effects of social support and depression.

Authors:  Soo Bi Lee; Sulki Chung; Jeong Seok Seo; Won Mi Jung; Il Ho Park
Journal:  Subst Abuse Treat Prev Policy       Date:  2020-02-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.